Skip to content

XOMA Corporation XOMA Share Buybacks

Share Buybacks at other companies

Royalty Pharma logo
Royalty PharmaRPRX
$50.1M-92.9%
Innoviva, Inc. logo
Innoviva, Inc.INVA
$20.25M
Zymeworks logo
ZymeworksZYME
$76.15M
Roivant Sciences logo
Roivant SciencesROIV
$208.29M-67.9%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$82.5M+70.9%
AbbVie logo
AbbVieABBV
$1.49B+54.9%

Other financials

Income statement

See full
Revenue$12.3M-22.6%
Operating income-$480.0K-108%
Net income$4.5M+88.6%
EPS (diluted)$0.17+183%

Balance sheet

See full
Cash & equivalents$85.6M-5.2%
Total debt$124.7M+9.0%
Total equity$92.9M+9.7%
Total assets$271.9M+27.8%

Cash flow

See full
Operating cash flow$6.1M+178%
CapEx$3.0K-29.4%
Free cash flow-$2.9M+36.0%

Valuation

See full
Market cap$746.04M+159%
Enterprise value$785.17M+152%
P/E22.1×
P/S15.4×+8.7×

Profitability

See full
Operating margin10.2%+5.5pp
Net margin69.6%+64.0pp
FCF margin-320%-118pp

Returns & leverage

See full
Return on equity38.1%+35.2pp
Debt / equity1.3×0.0×
Current ratio3.6×-2.0×

Where this comes from

Reported directly by XOMA Corporation in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.

The official record: XOMA Corporation’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about XOMA Corporation's share buybacks.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is XOMA Corporation's share buybacks?
XOMA Corporation (XOMA) reported share buybacks of $264K in Q1 2026.
How has XOMA Corporation's share buybacks changed year-over-year?
XOMA Corporation's share buybacks decreased by 51.6% year-over-year, from $545K to $264K.
What does share buybacks mean?
Cash used to buy back the company's own shares on the open market or through structured programs, reducing shares outstanding.